The University of Chicago Header Logo

Connection

Issam Awad to Middle Aged

Back to Details
This is a "connection" page, showing publications Issam Awad has written about Middle Aged.
Issam Awad
Connection Strength
1.474
Middle Aged
  1. Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo. J Am Heart Assoc. 2026 02 03; 15(3):e46943.
    View in: PubMed
    Score: 0.057
  2. Relevance of Lesion Volume as an Outcome in Cerebral Cavernous Malformation Drug Trial: Exploratory Analyses in Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept. Neurosurgery. 2026 Jun 01; 98(6):1395-1401.
    View in: PubMed
    Score: 0.056
  3. Identifying features of prior hemorrhage in cerebral cavernous malformations on quantitative susceptibility maps: a machine learning pilot study. J Neurosurg. 2025 Dec 01; 143(6):1567-1574.
    View in: PubMed
    Score: 0.055
  4. Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial. Lancet Neurol. 2025 Apr; 24(4):295-304.
    View in: PubMed
    Score: 0.054
  5. Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2025 06; 45(6):1153-1165.
    View in: PubMed
    Score: 0.053
  6. COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106101.
    View in: PubMed
    Score: 0.042
  7. Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105996.
    View in: PubMed
    Score: 0.042
  8. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2019 06 01; 84(6):1157-1168.
    View in: PubMed
    Score: 0.036
  9. Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis. Neurosurgery. 2018 12 01; 83(6):1260-1268.
    View in: PubMed
    Score: 0.035
  10. Patients with cranial dural arteriovenous fistulas may benefit from expanded hypercoagulability and cancer screening. J Neurosurg. 2018 10; 129(4):954-960.
    View in: PubMed
    Score: 0.032
  11. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Transl Stroke Res. 2018 02; 9(1):34-43.
    View in: PubMed
    Score: 0.032
  12. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations. J Neurosurg. 2017 Jul; 127(1):102-110.
    View in: PubMed
    Score: 0.030
  13. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations. AJNR Am J Neuroradiol. 2016 Jul; 37(7):1209-15.
    View in: PubMed
    Score: 0.029
  14. Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med. 2016; 10(3):255-64.
    View in: PubMed
    Score: 0.029
  15. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015 Oct; 35(10):1632-9.
    View in: PubMed
    Score: 0.027
  16. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015 Mar; 17(3):188-196.
    View in: PubMed
    Score: 0.026
  17. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014 Feb; 45(2):598-601.
    View in: PubMed
    Score: 0.025
  18. Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery. 2012 May; 70(5):1258-63; discussion 1263-4.
    View in: PubMed
    Score: 0.022
  19. A "pseudo-cavernoma" - an encapsulated hematoma of the choroid plexus. J Clin Neurosci. 2011 Jun; 18(6):846-8.
    View in: PubMed
    Score: 0.020
  20. Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. Neurosurgery. 2009 Mar; 64(3):436-45; discussion 445-6.
    View in: PubMed
    Score: 0.018
  21. Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery. 2008 Oct; 63(4):782-9; discussion 789.
    View in: PubMed
    Score: 0.017
  22. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery. 2006 Dec; 59(6):1278-84; discussion 1284-5.
    View in: PubMed
    Score: 0.015
  23. Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy. Stroke Vasc Neurol. 2025 12 23; 10(6):734-742.
    View in: PubMed
    Score: 0.014
  24. Recurrent somatic copy number alterations in resected cerebral cavernous malformations. Hum Genomics. 2025 12 09; 20(1):12.
    View in: PubMed
    Score: 0.014
  25. Impact of Minimally Invasive Surgery on Midline Shift and Outcomes in Large Supratentorial Spontaneous Intracerebral Hemorrhage: Post Hoc Analysis of MISTIE III. Neurocrit Care. 2026 02; 44(1):261-272.
    View in: PubMed
    Score: 0.014
  26. Association of Quality of Life Domains and Clinical Symptoms in Patients With Familial Cerebral Cavernous Malformation. J Am Heart Assoc. 2025 09 02; 14(17):e035926.
    View in: PubMed
    Score: 0.014
  27. Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial. CNS Drugs. 2025 09; 39(9):865-877.
    View in: PubMed
    Score: 0.014
  28. Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial. J Neurol Neurosurg Psychiatry. 2024 09 17; 95(10):892-898.
    View in: PubMed
    Score: 0.013
  29. Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage. Stroke Vasc Neurol. 2024 08 27; 9(4):446-456.
    View in: PubMed
    Score: 0.013
  30. Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis. J Stroke Cerebrovasc Dis. 2024 Jul; 33(7):107699.
    View in: PubMed
    Score: 0.013
  31. Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. Stroke. 2024 03; 55(3):541-547.
    View in: PubMed
    Score: 0.012
  32. Mechanistic Evaluation of Diffusion Weighted Hyperintense Lesions After Large Spontaneous Intracerebral Hemorrhage: A Subgroup Analysis of MISTIE III. Neurocrit Care. 2024 06; 40(3):1140-1150.
    View in: PubMed
    Score: 0.012
  33. Catheter Tract Hemorrhages and Intracerebral Hemorrhage Outcomes in the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Trial. Neurosurgery. 2024 02 01; 94(2):334-339.
    View in: PubMed
    Score: 0.012
  34. Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107227.
    View in: PubMed
    Score: 0.012
  35. Differential gene expression in human cerebrovascular malformations. Neurosurgery. 2003 Feb; 52(2):465-77; discussion 477-8.
    View in: PubMed
    Score: 0.012
  36. One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability. JAMA Neurol. 2022 09 01; 79(9):856-868.
    View in: PubMed
    Score: 0.011
  37. Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis. Stroke. 2022 06; 53(6):1847-1853.
    View in: PubMed
    Score: 0.011
  38. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery. 2002 Jan; 50(1):110-5; discussion 115-6.
    View in: PubMed
    Score: 0.011
  39. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage. JAMA Netw Open. 2021 12 01; 4(12):e2135773.
    View in: PubMed
    Score: 0.011
  40. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke. 2021 12; 52(12):3829-3838.
    View in: PubMed
    Score: 0.011
  41. Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery. 2001 Sep; 49(3):671-9; discussion 679-80.
    View in: PubMed
    Score: 0.011
  42. CSF and serum inflammatory response and association with outcomes in spontaneous intracerebral hemorrhage with intraventricular extension: an analysis of the CLEAR-III Trial. J Neuroinflammation. 2021 Aug 21; 18(1):179.
    View in: PubMed
    Score: 0.011
  43. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage. J Cereb Blood Flow Metab. 2021 11; 41(11):2944-2956.
    View in: PubMed
    Score: 0.010
  44. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage. Sci Immunol. 2021 02 19; 6(56).
    View in: PubMed
    Score: 0.010
  45. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery. 2001 Feb; 48(2):359-67; discussion 367-8.
    View in: PubMed
    Score: 0.010
  46. Temporal Evolution and Outcomes of Non-Traumatic Intracerebral Hemorrhage in Hospitalized Patients. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105584.
    View in: PubMed
    Score: 0.010
  47. Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105540.
    View in: PubMed
    Score: 0.010
  48. A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage. JAMA Neurol. 2020 Nov 01; 77(11):1390-1397.
    View in: PubMed
    Score: 0.010
  49. Intraoperative endovascular treatment as an adjunct to microsurgical clipping of paraclinoid aneurysms. J Neurosurg. 2000 Oct; 93(4):554-60.
    View in: PubMed
    Score: 0.010
  50. Impact of Guglielmi detachable coils on outcomes of patients with intracranial aneurysms treated by a multidisciplinary team at a single institution. J Neurosurg. 2000 Oct; 93(4):569-80.
    View in: PubMed
    Score: 0.010
  51. Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020 05 27; 11(1):2659.
    View in: PubMed
    Score: 0.010
  52. Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu. J Autoimmun. 2020 09; 113:102469.
    View in: PubMed
    Score: 0.010
  53. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance. J Neurosurg. 2021 03 01; 134(3):1147-1154.
    View in: PubMed
    Score: 0.010
  54. Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations. Neurosurg Focus. 2020 04 01; 48(4):E12.
    View in: PubMed
    Score: 0.010
  55. Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke. 2000 Apr; 31(4):834-40.
    View in: PubMed
    Score: 0.010
  56. Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery. 2000 Jan; 46(1):28-35; discussion 35-6.
    View in: PubMed
    Score: 0.009
  57. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032.
    View in: PubMed
    Score: 0.009
  58. Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery. 1999 Feb; 44(2):280-7; discussion 287-8.
    View in: PubMed
    Score: 0.009
  59. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999 Jan; 44(1):41-6; discussion 46-7.
    View in: PubMed
    Score: 0.009
  60. Influence of Bleeding Pattern on Ischemic Lesions After Spontaneous Hypertensive Intracerebral Hemorrhage with Intraventricular Hemorrhage. Neurocrit Care. 2018 10; 29(2):180-188.
    View in: PubMed
    Score: 0.009
  61. Occipital lobe vascular malformations: prevalence of visual field deficits and prognosis after therapeutic intervention. Neurosurgery. 1998 Sep; 43(3):415-21; discussion 421-3.
    View in: PubMed
    Score: 0.009
  62. Failure of the hypotensive provocative test during temporary balloon test occlusion of the internal carotid artery to predict delayed hemodynamic ischemia after therapeutic carotid occlusion. Surg Neurol. 1998 Aug; 50(2):147-55; discussion 155-6.
    View in: PubMed
    Score: 0.008
  63. The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial. Neurocrit Care. 2018 08; 29(1):23-32.
    View in: PubMed
    Score: 0.008
  64. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res. 2018 06 08; 122(12):1716-1721.
    View in: PubMed
    Score: 0.008
  65. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial. Neurology. 2017 Jul 25; 89(4):355-362.
    View in: PubMed
    Score: 0.008
  66. Cerebral vascular malformations adjacent to sensorimotor and visual cortex. Functional magnetic resonance imaging studies before and after therapeutic intervention. Stroke. 1997 Jun; 28(6):1130-7.
    View in: PubMed
    Score: 0.008
  67. Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovasc Dis. 2017; 43(5-6):223-230.
    View in: PubMed
    Score: 0.008
  68. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017 02 11; 389(10069):603-611.
    View in: PubMed
    Score: 0.008
  69. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016 Nov; 15(12):1228-1237.
    View in: PubMed
    Score: 0.007
  70. Giant aneurysms of the anterior circle of Willis: management outcome of open microsurgical treatment. Surg Neurol. 1996 May; 45(5):409-20; discussion 420-1.
    View in: PubMed
    Score: 0.007
  71. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995 Oct; 37(4):591-605.
    View in: PubMed
    Score: 0.007
  72. Determinants of external ventricular drain placement and associated outcomes in patients with spontaneous intraventricular hemorrhage. Neurocrit Care. 2014 Dec; 21(3):426-34.
    View in: PubMed
    Score: 0.007
  73. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol. 2014 Jul; 49(7):498-504.
    View in: PubMed
    Score: 0.006
  74. Radiosurgery and venous malformations. J Neurosurg. 1994 Jan; 80(1):171-3; author reply 174-5.
    View in: PubMed
    Score: 0.006
  75. Pathogenesis of subcortical hyperintense lesions on magnetic resonance imaging of the brain. Observations in patients undergoing controlled therapeutic internal carotid artery occlusion. Stroke. 1993 Sep; 24(9):1339-46.
    View in: PubMed
    Score: 0.006
  76. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014 Jun; 9(4):536-42.
    View in: PubMed
    Score: 0.006
  77. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993 Aug; 33(2):179-88; discussion 188.
    View in: PubMed
    Score: 0.006
  78. Giant aneurysms of the proximal anterior cerebral artery: report of three cases. Neurosurgery. 1993 Jul; 33(1):120-4; discussion 124-5.
    View in: PubMed
    Score: 0.006
  79. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013 Mar; 44(3):627-34.
    View in: PubMed
    Score: 0.006
  80. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke. 2013 Mar; 44(3):635-41.
    View in: PubMed
    Score: 0.006
  81. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.006
  82. Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care. 2012 Jun; 16(3):399-405.
    View in: PubMed
    Score: 0.006
  83. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med. 2012 May; 40(5):1601-8.
    View in: PubMed
    Score: 0.006
  84. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke. 2012 Jun; 43(6):1666-8.
    View in: PubMed
    Score: 0.005
  85. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov; 42(11):3009-16.
    View in: PubMed
    Score: 0.005
  86. Perioperative management and outcome after surgical treatment of anterior cerebral artery aneurysms. Can J Neurol Sci. 1991 May; 18(2):120-5.
    View in: PubMed
    Score: 0.005
  87. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011 Mar; 68(3):641-7; discussion 647-8.
    View in: PubMed
    Score: 0.005
  88. Intractable epilepsy and structural lesions of the brain: mapping, resection strategies, and seizure outcome. Epilepsia. 1991 Mar-Apr; 32(2):179-86.
    View in: PubMed
    Score: 0.005
  89. Ipsilateral leg weakness associated with carotid stenosis. Stroke. 1990 Sep; 21(9):1362-4.
    View in: PubMed
    Score: 0.005
  90. Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg. 1990 Jun; 72(6):839-50.
    View in: PubMed
    Score: 0.005
  91. Alcohol histories in hospital: does the age and sex of the patient make a difference? Br J Addict. 1990 Jan; 85(1):149-50.
    View in: PubMed
    Score: 0.005
  92. Internal carotid artery occlusion for cavernous segment aneurysm. Neurosurgery. 1989 Sep; 25(3):398-404.
    View in: PubMed
    Score: 0.005
  93. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery. 2009 Jul; 65(1):138-44; discussion 144-5.
    View in: PubMed
    Score: 0.005
  94. Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery. 1989 Apr; 24(4):557-60.
    View in: PubMed
    Score: 0.004
  95. Genomics of human intracranial aneurysm wall. Stroke. 2009 Apr; 40(4):1252-61.
    View in: PubMed
    Score: 0.004
  96. Effect of local anaesthetic volume (20 vs 5 ml) on the efficacy and respiratory consequences of ultrasound-guided interscalene brachial plexus block. Br J Anaesth. 2008 Oct; 101(4):549-56.
    View in: PubMed
    Score: 0.004
  97. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008; 105:217-20.
    View in: PubMed
    Score: 0.004
  98. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987 Mar-Apr; 18(2):365-72.
    View in: PubMed
    Score: 0.004
  99. Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups. Neurosurgery. 1987 Feb; 20(2):222-7.
    View in: PubMed
    Score: 0.004
  100. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke. 1986 Nov-Dec; 17(6):1090-7.
    View in: PubMed
    Score: 0.004
  101. Retrograde suction decompression of giant paraclinoid aneurysms using a No. 7 French balloon-containing guide catheter. Technical note. J Neurosurg. 2006 Sep; 105(3):479-81.
    View in: PubMed
    Score: 0.004
  102. Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurgery. 1986 Aug; 19(2):247-51.
    View in: PubMed
    Score: 0.004
  103. [Etiologic spectrum of intracerebral hemorrhage in young patients]. Neurochirurgie. 2006 Jun; 52(2-3 Pt 1):105-9.
    View in: PubMed
    Score: 0.004
  104. Focal parenchymal lesions in transient ischemic attacks: correlation of computed tomography and magnetic resonance imaging. Stroke. 1986 May-Jun; 17(3):399-403.
    View in: PubMed
    Score: 0.004
  105. Nocardial osteomyelitis of the spine with epidural spinal cord compression--a case report. Neurosurgery. 1984 Aug; 15(2):254-6.
    View in: PubMed
    Score: 0.003
  106. Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery. J Neurosurg. 1984 Apr; 60(4):771-6.
    View in: PubMed
    Score: 0.003
  107. Intravenous digital subtraction angiography: an index of collateral cerebral blood flow in internal carotid artery occlusion. Stroke. 1982 Jul-Aug; 13(4):469-72.
    View in: PubMed
    Score: 0.003
  108. Correlation of clinical and angiographic findings in brain ischemia with regional cerebral blood flow measured by the xenon inhalation technique. Neurosurgery. 1982 Jul; 11(1 Pt 1):1-5.
    View in: PubMed
    Score: 0.003
  109. Traumatic postsurgical aneurysm of the intracavernous carotid artery: a delayed presentation. Surg Neurol. 1982 Jul; 18(1):54-7.
    View in: PubMed
    Score: 0.003
  110. Patterns of functional magnetic resonance imaging activation in association with structural lesions in the rolandic region: a classification system. J Neurosurg. 2001 Jun; 94(6):946-54.
    View in: PubMed
    Score: 0.003
  111. A quality-of-life instrument for young hemorrhagic stroke patients. Stroke. 2001 Mar; 32(3):687-95.
    View in: PubMed
    Score: 0.003
  112. Case problems conference: thoracic spinal cord hernia. Neurosurgery. 2000 Jun; 46(6):1408-15.
    View in: PubMed
    Score: 0.002
  113. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000 Jun; 46(6):1454-9.
    View in: PubMed
    Score: 0.002
  114. Parenchymal perianeurysmal cystic changes in the brain: report of five cases. Radiology. 2000 Apr; 215(1):229-33.
    View in: PubMed
    Score: 0.002
  115. Comparative localization of auditory comprehension by using functional magnetic resonance imaging and cortical stimulation. J Neurosurg. 1999 Oct; 91(4):626-35.
    View in: PubMed
    Score: 0.002
  116. Creutzfeldt-Jakob disease in the elderly. Postgrad Med J. 1997 Sep; 73(863):557-9.
    View in: PubMed
    Score: 0.002
  117. Misdiagnosis of symptomatic cerebral aneurysm. Prevalence and correlation with outcome at four institutions. Stroke. 1996 Sep; 27(9):1558-63.
    View in: PubMed
    Score: 0.002
  118. Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery. 1996 Sep; 39(3):537-45; discussion 545-7.
    View in: PubMed
    Score: 0.002
  119. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery. 1996 May; 38(5):915-24; discussion 924-5.
    View in: PubMed
    Score: 0.002
  120. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996 Apr 11; 334(15):946-51.
    View in: PubMed
    Score: 0.002
  121. Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation. Electroencephalogr Clin Neurophysiol. 1994 Sep; 91(3):179-93.
    View in: PubMed
    Score: 0.002
  122. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology. 1994 Apr; 191(1):33-9.
    View in: PubMed
    Score: 0.002
  123. Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery. 1993 Oct; 33(4):547-54; discussion 554-5.
    View in: PubMed
    Score: 0.002
  124. Comparison and spacial correlation of interictal HMPAO-SPECT and FDG-PET in intractable temporal lobe epilepsy. Neurol Res. 1993 Jun; 15(3):160-8.
    View in: PubMed
    Score: 0.001
  125. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993 May; 32(5):730-5; discussion 735-6.
    View in: PubMed
    Score: 0.001
  126. Natural history of recurrent seizures after resective surgery for epilepsy. Epilepsia. 1991 Nov-Dec; 32(6):851-6.
    View in: PubMed
    Score: 0.001
  127. Natural history of the cavernous angioma. J Neurosurg. 1991 Nov; 75(5):709-14.
    View in: PubMed
    Score: 0.001
  128. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol. 1991 Jun; 48(6):631-6.
    View in: PubMed
    Score: 0.001
  129. Symptomatic Chiari malformation in adults: a new classification based on magnetic resonance imaging with clinical and prognostic significance. Neurosurgery. 1991 May; 28(5):639-45.
    View in: PubMed
    Score: 0.001
  130. Surgical management of syringomyelia: a five year experience in the era of magnetic resonance imaging. Neurol Res. 1991 Mar; 13(1):3-9.
    View in: PubMed
    Score: 0.001
  131. Periventricular lesions on MRI. Facts and theories. Stroke. 1989 Jul; 20(7):963-7.
    View in: PubMed
    Score: 0.001
  132. Proton magnetic resonance imaging in ischemic cerebrovascular disease. Ann Neurol. 1986 Oct; 20(4):502-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.